Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Yen-Ning Hsu"'
Autor:
Yu-Cheng Chang, Yi-Hao Chiang, Kate Hsu, Chih-Kuang Chuang, Chen-Wei Kao, Yi-Fang Chang, Ming-Chih Chang, Ken-Hong Lim, Hung-I Cheng, Yen-Ning Hsu, Caleb G. Chen
Publikováno v:
Blood Cancer Journal, Vol 11, Iss 11, Pp 1-10 (2021)
Abstract Tyrosine kinase inhibitors (TKIs) that target BCR-ABL are the frontline treatments in chronic myeloid leukemia (CML). Growing evidence has shown that TKIs also enhance immunity. Since gamma-delta T (γδT) cells possess the potent anticancer
Externí odkaz:
https://doaj.org/article/9de7eaa081b649b584d078d1f35041b7
Autor:
Ming-Chin Chang, Hung-I Cheng, Kate Hsu, Yen-Ning Hsu, Chen-Wei Kao, Yi-Fang Chang, Ken-Hong Lim, Caleb Gonshen Chen
Publikováno v:
Frontiers in Immunology, Vol 9 (2019)
Chronic myeloid leukemia (CML) is a hematological malignancy characterized by the presence of t(9;22) chromosomal translocation that results in BCR-ABL fusion gene. ABL tyrosine kinase inhibitors (TKIs), such as imatinib, nilotinib, and dasatinib, ar
Externí odkaz:
https://doaj.org/article/156f14f86c124cdfb856bcf487471e15
Autor:
Yi-Fang Chang, Yen-Ning Hsu, Hung-I Cheng, Yu-Cheng Chang, Chih-Kuang Chuang, Chen-Wei Kao, Caleb Gon-Shen Chen, Kate Hsu, Ken-Hong Lim, Yi-Hao Chiang, Ming-Chih Chang
Publikováno v:
Blood Cancer Journal
Blood Cancer Journal, Vol 11, Iss 11, Pp 1-10 (2021)
Blood Cancer Journal, Vol 11, Iss 11, Pp 1-10 (2021)
Tyrosine kinase inhibitors (TKIs) that target BCR-ABL are the frontline treatments in chronic myeloid leukemia (CML). Growing evidence has shown that TKIs also enhance immunity. Since gamma-delta T (γδT) cells possess the potent anticancer capabili
Autor:
Yen Ning Hsu, Hsei-Wei Wang, Wei Shone Chen, Kuen-Feng Chen, Chun Chi Lin, Tzu Chen Lin, Chueh Chuan Yen, Shung Haur Yang, Yuan Tzu Lan, Jen Kou Lin, Hao Wei Teng, Paul Chih-Hsueh Chen, Anna Fen Yau Li, Jeng Kai Jiang
Publikováno v:
Journal of Gastrointestinal Surgery. 16:1037-1047
The cancerous inhibitor of protein phosphatase 2A (CIP2A) oncoprotein is overexpressed in colon cancer tissue compared to normal colon mucosa. We investigated the impact of CIP2A on colon cancer. A tissue microarray consisting of 167 colon cancer spe
Autor:
Chunyu Liu, Tzeon Jye Chiou, Jin Hwang Liu, Liang Tsai Hsiao, Yen Ning Hsu, Ying Chung Hong, Po Min Chen, Jyh Pyng Gau, Yao Yu Hsieh, Cheng Hwai Tzeng, Han Nan Lin, Yuan Bin Yu
Publikováno v:
European Journal of Haematology. 86:237-245
We retrospectively examined the impact of hematopoietic stem cell transplantation (HSCT) during the first complete remission (CR1) in 81 patients with cytogenetically normal acute myeloid leukemia (CN-AML). Eligible patients were divided into three s
Autor:
Yuan Tzu Lan, Jeng Kai Jiang, Chia Jen Liu, Jin Huang Liu, Jen Kou Lin, Yen Ning Hsu, Tzu Chen Lin, Chun Chi Lin, Hao Wei Teng, Shung Haur Yang, Chueh Chuan Yen, Wei Shone Chen, Cheng Hwai Tzeng, Shih Ching Chang
Publikováno v:
Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 15(10)
More and more complications of extensive hepatic resection are being encountered in patients treated for liver metastases from colorectal cancer. This study aimed to determine the impact of liver abscess after hepatic resection on overall survival (O
Autor:
Yao-Yu, Hsieh, Ying-Chung, Hong, Liang-Tsai, Hsiao, Yuan-Bin, Yu, Jin-Hwang, Liu, Jyh-Pyng, Gau, Han-Nan, Lin, Yen-Ning, Hsu, Tzeon-Jye, Chiou, Po-Min, Chen, Cheng-Hwai, Tzeng, Chun-Yu, Liu
Publikováno v:
European journal of haematology. 86(3)
We retrospectively examined the impact of hematopoietic stem cell transplantation (HSCT) during the first complete remission (CR1) in 81 patients with cytogenetically normal acute myeloid leukemia (CN-AML). Eligible patients were divided into three s
Autor:
Jin-Hwang Liu, Yao-Yu Hsieh, Wei-Shone Chen, Yen-Ning Hsu, Gar-Yang Chau, Hao-Wei Teng, Kuang-Liang King, Tzu-Chen Lin, Chen-Hwai Tzeng, Jen-Kou Lin
Publikováno v:
International Journal of Colorectal Disease; Oct2010, Vol. 25 Issue 10, p1243-1249, 7p, 3 Charts, 1 Graph
Autor:
Yao-Yu Hsieh, Ying-Chung Hong, Liang-Tsai Hsiao, Yuan-Bin Yu, Jin-Hwang Liu, Jyh-Pyng Gau, Han-Nan Lin, Yen-Ning Hsu, Tzeon-Jye Chiou, Po-Min Chen, Cheng-Hwai Tzeng, Chun-Yu Liu
Publikováno v:
European Journal of Haematology; Mar2011, Vol. 86 Issue 3, p237-245, 9p, 4 Charts, 4 Graphs
Publikováno v:
Hematology/Oncology and Stem Cell Therapy, Vol 3, Iss 4, Pp 199-202 (2010)
Idiopathic hyperammonemia (IHA) had been reported in some patients with hematological malignancy after receiving intensive chemotherapy, following bone marrow transplantation, or after using 5-fluoro-uracil for some solid tumors. The chemotherapeutic